机译:r-thp-cop与未经治疗的弥漫性大b细胞淋巴瘤的患者患者患者患者:随机,开放标签,非流动性阶段3试验
First Department of Internal MedicineGifu University Graduate School of MedicineGifu Japan;
First Department of Internal MedicineGifu University Graduate School of MedicineGifu Japan;
Division of HematologyGifu Municipal HospitalGifu Japan;
Department of HematologyGifu Red‐Cross HospitalGifu Japan;
Department of HematologyGifu Prefectural General Medical CenterGifu Japan;
First Department of Internal MedicineGifu University Graduate School of MedicineGifu Japan;
Division of HematologyGifu Municipal HospitalGifu Japan;
First Department of Internal MedicineGifu University Graduate School of MedicineGifu Japan;
First Department of Internal MedicineGifu University Graduate School of MedicineGifu Japan;
Department of Internal MedicineKisogawa Municipal HospitalKisogawa Japan;
First Department of Internal MedicineGifu University Graduate School of MedicineGifu Japan;
First Department of Internal MedicineGifu University Graduate School of MedicineGifu Japan;
First Department of Internal MedicineGifu University Graduate School of MedicineGifu Japan;
First Department of Internal MedicineGifu University Graduate School of MedicineGifu Japan;
First Department of Internal MedicineGifu University Graduate School of MedicineGifu Japan;
First Department of Internal MedicineGifu University Graduate School of MedicineGifu Japan;
Department of Internal MedicineChuno Kosei HospitalSeki Japan;
Department of HematologyMatsunami General HospitalKasamatsu Japan;
Department of Pathology and Translational ResearchGifu University Graduate School of MedicineGifu;
Department of Pathology and Translational ResearchGifu University Graduate School of MedicineGifu;
Pathology DivisionGifu University HospitalGifu Japan;
Department of Pathology and Translational ResearchGifu University Graduate School of MedicineGifu;
First Department of Internal MedicineGifu University Graduate School of MedicineGifu Japan;
First Department of Internal MedicineGifu University Graduate School of MedicineGifu Japan;
diffuse large B cell lymphoma (DLBCL); non‐Hodgkin's lymphoma (NHL); pirarubicin (THP); R‐CHOP; R‐THP‐COP;
机译:r-thp-cop与未经治疗的弥漫性大b细胞淋巴瘤的患者患者患者患者:随机,开放标签,非流动性阶段3试验
机译:R-CHOP±硼替佐米在未经治疗的非女性中心性B细胞样(Non-GCB)亚型弥漫性大细胞淋巴瘤(DLBCL)患者中的随机2期开放标签研究:金字塔试验(NCT00931918) )
机译:利托妥昔单抗与THP-COP作为WRST线疗法的II型研究在拆除大B细胞淋巴瘤70岁以下的患者
机译:免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性:RU051417I-R-ICE(利妥昔单抗-异环磷酰胺-卡铂-依托泊苷)与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤(DLBCL)。
机译:新诊断的中国弥漫性大B细胞淋巴瘤患者的剂量密集型利妥昔单抗-CHOP与标准利妥昔单抗-CHOP:一项随机多中心开放标签的3期试验
机译:在前未经治疗的外周T细胞淋巴瘤(ChemO-T)中的患者(Chemo-T),Check对Gem-p:2阶段,多型,随机,开放标签试验